Fig. 3From: The NeST (Neoadjuvant systemic therapy in breast cancer) study: National Practice Questionnaire of United Kingdom multi-disciplinary decision makingPrefered modalities used in the monitoring of neoadjuvant systemic therapy response. Represented as percentage of MDTs using each modality for Fig. 3 a: neoadjuvant chemotherapy and Fig. 3 b neoadjuvant endocrine therapy. As some units use more than one imaging modality, percentages may add up to > 100%Back to article page